Aeterna Zentaris
AEZS
#10364
Rank
HK$0.13 B
Marketcap
HK$44.81
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -HK$16.03

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$16.05. In 2022 the company made an earnings per share (EPS) of -HK$36.66 a decrease over its 2021 EPS that were of -HK$14.26.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$16.03
2022-HK$36.66157.14%
2021-HK$14.26-41.48%
2020-HK$24.36-64.46%
2019-HK$68.55-240%
2018HK$48.96-122.32%
2017-HK$219.35-53.53%
2016-HK$472.00-86.71%
2015-HK$3,553-35.21%
2014-HK$5,484-216.67%
2013HK$4,700-123.3%
2012-HK$20,173-40.8%
2011-HK$34,078-6.45%
2010-HK$36,428-27.91%
2009-HK$50,529-61.61%
2008-HK$131,61183.61%
2007-HK$71,681-195.31%
2006HK$75,206178.26%
2005HK$27,027-330%
2004-HK$11,751-80.05%
2003-HK$58,90117.78%
2002-HK$50,010515.93%
2001-HK$8,119-68.6%
2000-HK$25,861119.62%
1999-HK$11,775-3.63%
1998-HK$12,219

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$54.99-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$20.05-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.89-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$20.45-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA